During melanoma development, transformed cells evade keratinocyte-mediated control by downregulating cell adhesion molecules. This study investigated the regulation of cell adhesion by hepatocyte growth factor (HGF) in melanoma. Melanocytes and two melanoma lines, WM164 and WM35, expressed normal level E-cadherin and Desmoglein 1, whereas most melanomas (18 out of 20) expressed no E-cadherin and signi®cantly reduced Desmoglein 1. Overexpression of dominant negative Ecadherin and Desmoglein in melanocytes demonstrated that both molecules contribute to adhesion between melanocytes and keratinocytes. In contrast to melanocytes, most melanomas expressed HGF. All melanocytic cells expressed the HGF receptor c-Met, and autocrine HGF caused constitutive activation of c-Met, MAPK and PI3K. When autocrine activation was induced with HGF-expressing adenovirus, E-cadherin and Desmoglein 1 were decreased in melanocytes, WM164 and WM35. MAPK inhibitor PD98059 and PI3K inhibitor wortmannin partially blocked the downregulation, suggesting that both pathways are involved in this process. c-Met was coimmunoprecipitated with E-cadherin, Desmoglein 1 and Plakoglobin, suggesting that they form a complex (es) that acts to regulate intercellular adhesion. Together, the results indicate that autocrine HGF decouples melanomas from keratinocytes by downregulating E-cadherin and Desmoglein 1, therefore frees melanoma cells from the control by keratinocytes and allows dissemination of the tumor mass. Oncogene (2001) 20, 8125 ± 8135.
Introduction
The incidence of cutaneous melanoma has risen rapidly in the last several decades (Parker et al., 1997; Ries et al., 2000) . Melanoma is notorious for its propensity to metastasize and its poor response to current therapeutic regimens. The transition from benign lesions to invasive, metastatic cancer occurs through a complex process involving changes in expression and function of oncogenes or tumor suppressor genes , as well as changes that provide tumor cells with the ability to overcome cell ± cell adhesions and microenvironmental controls and to invade surrounding tissues and translocate to distant tissues and organs (Johnson, 1999; Li and Herlyn, 2000) .
In the human epidermis, melanocytes residing at the basement membrane are interspersed among basal keratinocytes. E-cadherin is physiologically expressed on the cell surface of keratinocytes and melanocytes, and is the major adhesion molecule between the two cell types (Hsu et al., 1996; Tang et al., 1994) . A progressive loss of E-cadherin expression occurs during melanoma development (Danen et al., 1996; Hsu et al., 1996; Scott and Cassidy, 1998; Silye et al., 1998) .
Restoration of E-cadherin expression in melanoma cells results in restored keratinocyte-mediated growth control and downregulated expression of invasionrelated adhesion receptors .
Besides E-cadherin-mediated adherens junctions, desmosomes are also believed to play an important role in maintaining human skin homeostasis (Garrod, 1993) . Desmosomes contain specialized cadherin adhesion molecules (Desmogleins and Desmocollins) associating with various cytoplasmic proteins such as Desmoplakins and Plakoglobin (Garrod, 1993; Koch and Franke, 1994; Kowalczyk et al., 1999; North et al., 1999) . Desmosomes provide the cells with binding domains for intermediate ®laments of the cytokeratin network and are required for tissue organization (Bornslaeger et al., 1996; Kouklis et al., 1994; Kowalczyk et al., 1997; Smith and Fuchs, 1998; Stappenbeck and Green, 1992) . Plakoglobin (g-catenin) is also part of the cadherin ± catenin complex in adherens junctions Butz and Kemler, 1994; Lewis et al., 1997) and may mediate crosstalk between adherens junctions and desmosomes (Lewis et al., 1997) . Reduction or loss of desmosomes may contribute to the invasive and metastatic behavior of various tumors, for example transitional cell carcinoma of the bladder (Conn et al., 1990) and squamous cell carcinomas (Depondt et al., 1999; Krunic et al., 1996; Shinohara et al., 1998) . Reduction in desmosome formation was correlated with invasion and with reduction in E-cadherin staining (Shinohara et al., 1998) . Therefore, desmosomes appear to have tumor-suppressor properties. In fact, overexpressing desmosomal cadherins in squamous cell carcinoma cells inhibited invasiveness (De Bruin et al., 1999; Tada et al., 2000) .
Hepatocyte growth factor (HGF) is a multifunctional cytokine acting as mitogen, motogen and morphogen for many epithelial cells (Gherardi et al., 1989; Nakamura et al., 1989; Stoker et al., 1987) through its tyrosine kinase receptor c-Met (Bottaro et al., 1991b) , which is present in epithelial cells and melanocytes (Bottaro et al., 1991a; Sonnenberg et al., 1993) . HGF is physiologically secreted by cells of mesenchymal origin and acts on neighboring epithelial cells through a paracrine loop (Iyer et al., 1990; Rosen et al., 1994) . However, coexpression of HGF and cMet has been identi®ed in a variety of transformed cells and tumors both in vitro and in vivo and shown to be involved in tumor development and invasion (Bellusci et al., 1994; Moriyama et al., 1999; Rong et al., 1992; Tamatani et al., 1999; To and Tsao, 1998; Vande Woude et al., 1997) .
HGF/c-Met signaling has been implicated in the development of melanoma (Hendrix et al., 1998; Natali et al., 1993; Rusciano et al., 1998) . HGF stimulates proliferation and motility of human melanocytes (Halaban et al., 1992; Imokawa et al., 1998; Kos et al., 1999) . In transgenic mice that ubiquitously expressed HGF, ectopic localization of melanocytes and hyperpigmentation in skin were observed (Takayama et al., 1996) and melanoma arose spontaneously (Kos et al., 1999; Otsuka et al., 1998; Takayama et al., 1997) . In these mice, ultraviolet radiation-induced carcinogenesis was accelerated (Noonan et al., 2000) . It is suggested that cMet autocrine activation induced development of malignant melanoma and acquisition of the metastatic phenotype (Otsuka et al., 1998) . However it is unknown whether the autocrine loop actually exists in human melanoma, and the mechanisms by which HGF induces human melanoma remain unclear.
The purpose of the study was to address the potential role of HGF in human melanoma. Our results indicate that an HGF autocrine loop disrupts adhesion between melanocytes and keratinocytes by downregulating Ecadherin and Desmoglein 1, resulting in decoupling melanocytic cells from the control by keratinocytes, which may allow uncontrolled proliferation of cancer cells and dissemination of the tumor mass.
Results
Desmoglein 1 is downregulated in melanoma cell lines, and its expression levels correlates with those of E-cadherin During melanoma development, there is a progressive loss of E-cadherin expression (Hsu et al., 1996; Li and Herlyn, 2000) . We hypothesized that cell-cell adhesions have to be disrupted before malignant cells can migrate and metastasize to remote locations; and that besides E-cadherin-mediated adherens junctions, other types of adhesive junctions have to be attenuated as well. Since Desmosomes are important in maintaining human skin homeostasis (Green and Gaudry, 2000) , they are likely to be a major target of cell ± cell detachment during transformation. Western blots (Figure 1a) showed that both keratinocytes (FK113) and primary melanocytes (FOM73) expressed high levels of Desmoglein 1, while the majority of melanoma cells (18 out of 20, only eight lines shown) expressed very little Desmoglein 1. There are exceptions, however. Two lines, WM35 and WM164, did express Desmoglein 1 at levels comparable to those in keratinocytes or melanocytes. These two cell lines are exceptional in that, unlike other melanoma cells, they are E-cadherin positive ( Figure  1a ), suggesting that there is a correlation between the levels of E-cadherin and those of Desmoglein 1 in melanoma cells. Desmoglein 2 and Desmoglein 3 were not detectable by Western blots in either normal melanocytes or melanoma cells of various stages (data not shown). Since Plakoglobin (g-catenin) is shared by both adherens junctions and desmosomes (Cowin et ., 1986; Franke et al., 1989; Kowalczyk et al., 1999; Mathur et al., 1994; Roh and Stanley, 1995; Troyanovsky and Leube, 1998) , and loss of Plakoglobin in murine melanoma cell lines has been reported (Jouneau et al., 2000) , we also tested its expression in melanoma cells. Although reduced expression and absence were seen in some cell lines (Figure 1a) , there was no clear trend. Immuno¯uorescence staining showed that in Desmoglein-positive cells (FOM73 and WM35), Desmoglein 1 was concentrated at the cell ± cell contact areas whereas in Desmoglein-low cells such as 1205Lu, no distinct staining was observed (Figure 1b) .
Desmoglein 1 functions as a co-receptor for E-cadherin in mediating cell-cell adhesion between melanocytes and keratinocytes To test the hypothesis that desmosomes function together with adherens junctions to mediate cell ± cell adhesion between melanocytes and keratinocytes, we expressed dominant negative E-cadherin (E-cadDEC) and Desmoglein 3 (Dsg3DEC) (Hanakawa et al., 2000) in melanocytes. Dsg3DEC was originally made to target Desmoglein 3, but later shown to be able to disrupt Desmoglein 1 as well (Hanakawa et al., unpublished observation) . After con®rming their expression in melanocytes (Figure 2a,b) , we used cell adhesion assays to test their role in melanocytekeratinocyte interactions (Figure 2c ). E-cadDEC signi®cantly (42% reduction) disrupted adhesion between the two cell types, whereas Dsg3DEC alone didn't make a signi®cant dierence. Intriguingly, when both Dsg3DEC and E-cadDEC were introduced to melanocytes, a strong disruption (79% reduction) was obtained ( Figure 2c ). This suggests that disruption of Desmoglein alone is apparently not enough to break cell ± cell adhesion, however it can further weaken the interaction if E-cadherin-mediated adhesion is also lost.
In the search for the possible mechanisms underlying the downregulation of Desmoglein and E-cadherin, we failed to detect gene deletion or promoter methylation in our panel of melanoma lines (data not shown). This is in contrast to what has been shown in other cancer types (for review, see Hirohashi, 1998) , but is consistent with observations made by others in melanoma (Poser et al., 2001) . Therefore, we investigated whether abnormal growth factor expression caused the downregulation of E-cadherin and/or Desmoglein.
Melanoma cells, but not normal melanocytes, express HGF, which causes constitutive activation of c-Met, MAPK and PI3K in melanoma cells During screening of growth factors, we found that the majority of melanoma cells express HGF (Figure 3a,b) . In normal skin, HGF is secreted by cells of mesenchymal origin such as ®broblasts (Stoker et al., 1987) (FF2441 in Figure 3a (Li et al., 2001) . To test the hypothesis that autocrine HGF is, at least in part, responsible for it, we used HGF blocking antibody to treat 1205Lu melanoma cells. After HGF neutralization, a signi®cant decrease in phosphorylation of both MAPK ( Figure 5b ) and AKT ( Figure 5c ) was obtained. Similar results were seen in WM115 cells (data not shown).
Sustained HGF stimulation causes downregulation of both E-cadherin and Desmoglein 1 in melanocytic cells through PI3K and MAPK pathways
Increased proliferation of human melanocytes in vitro by HGF has previously been reported (Halaban et al., 1992; Imokawa et al., 1998; Matsumoto et al., 1991) . However, its mitogenic activity became obvious only when it acted together with other growth factors such as bFGF (Halaban et al., 1992) . We did not observe signi®cant growth stimulation in either melanocytes or melanoma cells after HGF treatment alone (data not shown). On the contrary, a dramatic decrease in the expression levels of Desmoglein 1 and E-cadherin were detected in melanocytes, WM164 and WM35 melanoma cells exposed to continuous HGF stimulation for three days (Figure 6 ). An adenoviral vector Ad.CMV.rhHGF (Phaneuf et al., 2000) was then used at 20 pfu/cell (corresponding to 30 ng/ml at 72 h) to introduce an autocrine loop in these cells and to ensure sustained stimulation. Under the same condition, expression of Connexin 43 did not change ( Figure 6 ). Noticeably, stimulation of melanocytes with one pulse or LacZ/Ad5 (20 pfu/ml). Forty-eight hours later, cells were lysed and immunoprecipitated with anti-c-Met antibody. The immunoprecipitated proteins were separated by SDS-polyacrylamide gel electrophoresis and hybridized against anti-phosphotyrosine antibody. (c) MAPK and AKT activation by exogenous HGF in melanocytes. FOM73 cells were cultured in melanocyte medium with reduced FBS (1%). Human recombinant HGF was added to the culture medium at a ®nal concentration of 100 ng/ml. Twenty minutes later cells were lysed and the lysates were subject to Western blots using anti-p44/42 MAPK, anti-phospho-p44/42 MAPK (Thr202/Tyr204), anti-Akt and anti-phospho-Akt (Ser473) antibodies of recombinant protein at 50 ng/ml over 5 and 12 h did not alter E-cadherin or Desmoglein expression (data not shown), suggesting that continuous stimulation is necessary for the observed changes. Because it is known that HGF stimulation can initiate multiple signal transduction pathways, including the MAPK and PI3K cascades (Ponzetto et al., 1994) , we were interested to know whether the downregulation of adhesion molecules depends on these pathways. When HGF neutralizing antibodies (10 mg/ml) were added to Ad.CMV.rhHGF transduced melanocytes, downregulation of E-cadherin and Desmoglein 1 was abolished (Figure 7) . The same eect was obtained in wortmannin (30 mM) treated cells (Figure 7 ). PD98059 (10 mM and 50 mM, data not shown) was less eective in blocking the downregulation (Figure 7) , suggesting that although both PI3K and MAPK are involved, PI3K pathway might be more critical.
Desmoglein 1, E-cadherin, c-Met and Plakoglobin can be co-immunoprecipitated from melanocytic cells
It has been previously shown that c-Met is co-localized with b-catenin and E-cadherin at regions of cell ± cell contact in human colon and breast cancer cell lines (Hiscox and Jiang, 1999a; Kamei et al., 1999) . Immuno¯uorescence assays showed that c-Met, Ecadherin and Desmoglein 1 have similar subcellular distribution in melanocytic cells (Figure 8a ). Since all of the above molecules are membrane-bound proteins, membranous co-localization doesn't necessarily suggest direct physical interaction. To test the possibility that physical interactions underlie the crosstalk between HGF/c-Met signaling and adhesion receptor regulation, we investigated the complex formation by immunoprecipitation analyses. We were able to detect Desmoglein 1, Plakoglobin, c-Met and E-cadherin in the complexes pulled down by either anti-Desmoglein 1 antibody or anti-Plakoglobin antibody (Figure 8b ) in keratinocytes (FK113) and melanocytes (FOM73). WM278 expresses no E-cadherin, but the other components apparently also form complexes. The speci®city of the interaction was con®rmed by probing the same blots with anti-IGF-R1 antibody. IGF-R1 was not detected in the immunoprecipitants, but it was Figure 5 HGF autocrine causes constitutive activation of c-Met, MAPK and PI3K. 1205Lu melanoma cells were cultured in W489 medium supplemented with 2% FBS until 90% con¯uence. Then the cells were starved in`protein free' medium for 24 h before antibodies were added. Both control antibody (IGF-1 neutralizing antibody) and HGF neutralizing antibody were initially added at 10 mg/ml, then replenished by adding additional 5 mg/ml every 24 h. PD98059 (10 mM) and wortmannin (30 mM) were added in control samples to con®rm the speci®city. At selected time points, cells were lysed and the lysates were subject to immunoprecipitation (for c-Met activation) and Western blots using antiphosphotyrosine, anti-p44/42 MAPK, anti-phospho-p44/42 MAPK (Thr202/Tyr204), anti-Akt and anti-phospho-Akt (Ser473) antibodies Figure 6 HGF autocrine induces downregulation of both Ecadherin and Desmoglein 1 in melanocytes and E-cadherinpositive, Desmoglein-positive melanoma cells. Melanocyte (FOM73) and melanoma lines WM164, WM35 were infected with Ad.CMV.rhHGF (20 pfu/cell) or LacZ/Ad5 (20 pfu/ml). 72 h (FOM73) or 96 h (melanoma cells) later, whole-cell protein extracts were subject to immunoblotting using anti-E-cadherin, anti-Desmoglein 1 and anti-Connexin 43 antibodies. b-Actin was used as a loading control. The numbers represent the quantitated intensities relative to corresponding control experiments detectable in whole cell extract (data not shown). To test whether HGF treatment has an eect on the physical interaction, WM35 and WM164 melanoma cells were treated with 100 ng/ml HGF for 30 min before immunoprecipitation (Figure 8c ). Using anti-cMet antibody, we were able to pull down E-cadherin and Desmoglein 1, which further demonstrates the existence of c-Met/E-cadherin/Desmoglein 1 complexes. HGF activation apparently has no substantial eect on the complex formation (Figure 8c ).
Discussion
Previous studies have documented the functional importance of cell adhesion molecules in normal skin homeostasis and in melanoma development Johnson, 1999; Li and Herlyn, 2000) . Here, we provide evidence that crosstalk between cell adhesion molecules and growth factor HGF is responsible for dysregulated skin homeostasis and tumor development. Speci®cally, the results demonstrate that: (1) Desmoglein 1 functions as a co-receptor for E-cadherin in mediating cell adhesion between melanocytes and keratinocytes. Although both E-cadherin and Desmoglein 1 are highly expressed in normal melanocytes, they are absent or substantially reduced in melanoma cells. (2) Melanoma cells, but not normal melanocytes, express HGF, which causes sustained activation of the HGF receptor c-Met and its downstream eectors MAPK and AKT/PKB. (3) Prolonged HGF stimulation causes downregulation of E-cadherin and Desmoglein 1, which is MAPK-and PI3K-dependent. (4) Desmoglein 1, E-cadherin, Plakoglobin and c-Met can be co-immunoprecipitated from melanocytic cells, which may underline the mechanism by which Ecadherin and Desmoglein 1 are coordinately downregulated by c-Met activation.
Adhesive interactions between cells are dynamic and regulated during tissue development and homeostasis Green and Gaudry, 2000; Gumbiner, 1996; Li and Herlyn, 2000; Steinberg, 1996; Takeichi, 1995) . They not only glue cells together, but also regulate intercellular and intracellular signaling pathways that control cell motility, growth and dierentiation. Cell scattering requires the attenuation or dissociation of cell ± cell adhesion (Bauer et al., 1998; Drubin and Nelson, 1996; Gumbiner, 1996) . Previous studies have shown a progressive loss of E-cadherin expression during melanoma development (Hsu et al., 1996; Johnson, 1999) . In the present study, we, for the ®rst time, demonstrated that Desmoglein expression is greatly reduced in melanoma cells. Although the levels of desmocollin expression in melanoma cells are not clear, downregulation or were transduced with Ad.CMV.rhHGF at 20 pfu/cell. In the neutralizing antibody-treated group, antibody (10 mg/ml) were added 12 h after transduction and replenished with additional 5 mg/ml for every 24 h. In inhibitors-treated groups, wortmannin (30 mM) or PD98059 (10 mM) were added 12 h after transduction. Seventy-two hours after adenoviral transduction, whole-cell protein extracts were subject to immunoblotting using anti-Ecadherin and anti-Desmoglein 1 antibodies. b-Actin was used as a loading control. The numbers represent the quantitated intensities relative to corresponding control experiments and WM164 melanoma cells were treated with 100 ng/ml HGF or vehicle for 30 min, followed by cell lysis and immunoprecipitation with anti-c-Met antibodies. Immunoprecipitants were separated on gel, transferred onto PVDF membrane and probed with anti-E-cadherin, anti-Desmoglein 1, anti-c-Met antibodies dysfunction of Desmoglein itself should be enough to attenuate adhesion (Amagai et al., 1992 (Amagai et al., , 1994 (Amagai et al., , 1996 Armstrong et al., 1999; Koch et al., 1997; Rickman et al., 1999; Stanley, 1993) . Since Desmoglein can contribute to the adhesion mainly mediated by Ecadherin, reduction or loss of Desmoglein and Ecadherin at the same time may free the melanocytic cells from microenvironmental control by keratinocytes, which contributes to the invasive and metastatic behavior of melanoma Li and Herlyn, 2000; Shinohara et al., 1998) .
In contrast to other cancer types (for review, see Hirohashi (1998) ), our study and others (Poser et al., 2001) showed that loss of E-cadherin in melanoma cell lines does not usually involve mutations in the Ecadherin gene or promoter methylation. This prompted us to investigate the possibility that abnormal growth factor expression causes the downregulation of Ecadherin and/or Desmoglein. During the screen, we found that a majority of melanoma cells tested, but not normal primary melanocytes, synthesize and secrete HGF. Physiologically, HGF is secreted by cells of mesenchymal origin and acts as mitogen, motogen and morphogen for many epithelial cells (Gherardi et al., 1989; Nakamura et al., 1989; Stoker et al., 1987) and is therefore considered a paracrine factor. Although the c-Met signaling pathway has been implicated in human melanomas (Hendrix et al., 1998; Natali et al., 1993) , there has been no report on how c-Met is activated or the source of its ligand HGF. Our study showed that HGF can be provided by not only ®broblasts (paracrine), but also, more importantly, melanoma cells themselves (autocrine). The latter appears to play a much more important role in melanoma development because ®broblasts constantly express HGF, even under normal conditions. Endogenously expressed HGF causes sustained activation of c-Met and its downstream eectors MAPK and PI3K. Furthermore, when E-cadherin-and Desmoglein-positive cells were exposed to prolonged HGF treatment, the expression levels of the two adhesion molecules were greatly reduced. Interestingly, pulse treatment with HGF didn't cause downregulation of either E-cadherin or Desmoglein, suggesting that continuous stimulation is necessary for the observed changes. It has been shown previously that HGF could disrupt intercellular junctions in normal and tumor cells (Hiscox and Jiang, 1999b; Stoker et al., 1987; Takeichi et al., 1994) . However, in those cases, HGF decreased cell ± cell contact without apparent loss of E-cadherin expression, which may represent a rapid eect of HGF stimulation occurring via post-translational modi®ca-tion.
It has been shown that activation of both MAPK (p42/p44) and PI3K is required for HGF-induced motility (Marshall, 1996; Ponzetto et al., 1994; Potempa and Ridley, 1998; Royal and Park, 1995) . Using the MAPK inhibitor PD98059 and the PI3K inhibitor wortmannin, we showed that both pathways are involved in the downregulation. However, the downstream molecule that is directly responsible for the downregulation is unclear. Among the candidate genes are zinc ®nger transcription factors Snail and/or Slug. Slug has been shown to play a critical role in HGF-induced desmosome dissociation in a bladder carcinoma cell line (Savagner et al., 1997) . In melanoma cells, activation of Snail expression plays an important role in downregulation of E-cadherin (Poser et al., 2001) . The role of Snail/Slug in HGFinduced downregulation of E-cadherin and Desmoglein is now under further investigation.
One important aspect of HGF is its mitogenic activity (Vande Woude et al., 1997) . However, we did not detect a signi®cant increase in melanocytic cell proliferation after either pulse or prolonged HGF stimulation, which is in concert with previous reports (Halaban et al., 1993; Rusciano et al., 1998) , suggesting that for melanocytic cells, HGF is not a potent mitogen (Halaban et al., 1992; Tamatani et al., 1999) . The results also suggest that growth and motility are separable events mediated by dierent factors, pathways and mechanisms. IGF-1 (Rodeck et al., 1987) and bFGF (Halaban et al., 1992; Meier et al., 2000) are most important mitogens for melanocytic cells.
Besides the downregulation of E-cadherin and Desmoglein, an HGF autocrine loop in melanoma has other important implications. For example, a recent study showed that activation of a v b 3 can be induced by HGF (Trusolino et al., 1998) . Upregulation of a v b 3 has been implicated in melanomas (Albelda et al., 1990; Hsu et al., 1998; Van Belle et al., 1999) . This has implications for invasion processes, particularly in the context that activation of c-Met by HGF leads to invasiveness of melanocytic cells.
Another important observation made in this study is the physical interaction among c-Met, E-cadherin, Desmoglein 1 and Plakoglobin. It is not clear, however, whether any one component can interact with all others directly. It has been shown previously that c-Met is co-localized with b-catenin and Ecadherin at regions of cell ± cell contact in human colon and breast cancer cell lines (Hiscox and Jiang, 1999a; Kamei et al., 1999) . Interestingly, c-erbB-2 also co-immunoprecipitates with E-cadherin-catenin (b-and g-catenin) complex (Kanai et al., 1995; Ochiai et al., 1994) , and EGF receptor physically interacts with bcatenin , suggesting that the physical interaction between tyrosine kinase receptors and cell adhesion molecules may be a common scheme underlying the functional crosstalk and regulation between the two families of molecules (Klymkowsky and Parr, 1995) .
Materials and methods

Cell culture
Human melanoma cells were isolated from clinically and histologically de®ned lesions (Satyamoorthy et al., 1997) . Cells were maintained in medium W489, a 4 : 1 mixture of MCDB153 and L15, supplemented with 2% heat-inactivated FBS and insulin (5 mg/ml) in a 378C, 5% CO 2 atmosphere at constant humidity. For growth in`protein-free' media, FBS and insulin were omitted from the medium. Primary human dermal ®broblasts were initiated as explant cultures from trypsin-treated and epidermis-stripped neonatal foreskin, and maintained in Dulbecco's Modi®ed Eagle's medium (DMEM) supplemented with 10% FBS. Human melanocytes were isolated from foreskin and maintained in MCDB153 medium supplemented with FBS, endothelin-3 (ET-3) and stem cell factor (SCF). Human keratinocytes were isolated from foreskin and maintained in SFM (GIBCO-BRL). Transcomplementing 293 cells, a cell line immortalized and transformed by adenovirus E1a and E1b, were obtained from the Vector Core at the Institute for Human Gene Therapy (University of Pennsylvania, Philadelphia, PA, USA) and grown in DMEM with 10% FBS. All tissue culture reagents were purchased from Sigma Chemical Co. (St. Louis, MO, USA) and GIBCO-BRL (Gaithersburg, MD, USA).
Antibodies and reagents
Mouse anti-E-cadherin, -Desmoglein 1, -g-Catenin (Plakoglobin) and -phosphotyrosine (PY20) mAbs were from Transduction Laboratories, Inc. 
Adenoviral vectors
The recombinant adenoviral vector Ad.CMV.rhHGF was kindly provided by Dr James Wilson of the University of Pennsylvania, Philadelphia, PA, USA (Phaneuf et al., 2000) . The adenoviral vectors AxCANCre (Kanegae et al., 1995 Miyake et al., 1996) , AxCALNLDsg3DEC and AxCALNLDEcadDEC were described (Hanakawa et al., 2000) . Plaque-puri®ed virus propagated in 293 cells was puri®ed by ultracentrifugation in a cesium chloride gradient. Viral titer was assayed by plaque formation in permissive 293 cells. Control adenoviral vector containing the LacZ cDNA (LacZ/Ad5) was purchased from Vector Core at the Institute for Human Gene Therapy, University of Pennsylvania, Philadelphia, PA, USA.
Viral infection of melanocytes and melanoma cells
Optimal viral concentrations for infection were determined as the amounts of virus required to yield the desired levels of gene expression without apparent alteration in cellular phenotype or toxicity. Subcon¯uent melanocytes and melanoma cells were infected with adenoviruses for 2 ± 4 h at 378C in protein-free W489 medium. Viral suspension was then replaced with culture medium. Because dominant negative Desmoglein-3 vector AxCALNLDsg3DEC and E-cadherin vector AxCALNLEcadDEC were made using the Cre-loxP system (Hanakawa et al., 2000) , AxCANCre was co-infected with AxCALNLDsg3DEC or AxCALNLEcadDEC at a ratio of 1 : 1, respectively. Cells were allowed to recover for at least 24 h before assay.
Immunoblotting
For immunoblotting, cells were washed with PBS and harvested in RIPA buer. Total protein concentrations were measured using the bicinchoninic acid (BCA) assay (Pierce Chemical Co. Rockford, IL, USA). Samples were loaded at 15 mg/lane and separated on 8% SDS-polyacrylamide gels and transferred to polyvinylidene di¯uoride (PVDF) membranes and probed with speci®c primary antibodies. To detect the signal, peroxidase-conjugated secondary antibody was added, followed by exposure using enhanced chemiluminescence (ECL) (Amersham, Arlington Heights, IL, USA). Some of the immunoblots were quanti®ed using NIH Image (version 1.61).
Immunofluorescence
Melanocytes and melanoma cells were seeded in 8-well chamber slides (Lab-Tek, Nunc, Inc., Naperville, IL, USA). Cells were washed with cold PBS, ®xed in 4% paraformaldehyde at 48C for 5 min, permeabilized with 0.5% Triton X-100 in PBS for 20 min at room temperature, blocked with 5% BSA, and incubated with primary antibody (anti-Desmoglein IgG 1 , dilution 1 : 50), followed by biotin-conjugated goat anti-mouse IgG 1 and Cy3-conjugated streptavidin. Primary and secondary antibody incubations were performed at room temperature for 1 h with three washings in between. Cells were mounted in anti-fade medium Gel Mount (Biomeda Corp.) and examined by¯uorescence microscopy.
Immunoprecipitation
To investigate the status of c-Met phosphorylation, subconuent melanoma cells were infected with LacZ or Ad.CMV.rhHGF (20 pfu/cell) and cultured for 48 h. In neutralizing antibody-treated group, HGF neutralizing antibody (®nal concentration 10 mg/ml) was added to serum-free medium 24 h before lysis. Cells were washed with cold PBS containing 1 mM Na 3 VO 4 , and rapidly scraped into 200 ml PBS containing 1% Triton X-100, 1% NP40, 1 mM Na 3 VO 4 , 1 mM phenylmethyl sulfonyl¯uoride (PMSF), and protease inhibitors (1 mg/ml leupeptin, aprotinin and pepstatin). After incubation on ice for 15 min, the extracts were separated by centrifugation at 13 000 g for 10 min. The supernatants were used for immunoprecipitation using an anti-c-Met antibody (5 mg) for 1 h at 48C with shaking. Protein A ± G sepharose CL-4B beads (Pharmacia Biotech, Uppsala, Sweden) were then added and incubated for 12 h. Samples were washed four times with lysis buer, boiled in Laemmli buer containing b-mercaptoethanol, and subjected to electrophoresis on an 8% SDS-polyacrylamide gel. Separated proteins were transferred onto PVDF membrane and detected by antiphosphotyrosine primary antibody (PY20) and peroxidaseconjugated secondary antibody. Signals were detected using ECL.
To investigate c-Met/Desmoglein/E-cadherin complexes, cells cultured in their optimal media were lysed in 10 mM Tris-HCl (pH 7.4), 1% NP-40, 1% Triton X-100, 2 mM CaCl 2 , 150 mM NaCl, 1 mM PMSF and protease inhibitors (1 mg/ml leupeptin, aprotinin and pepstatin). The extracts were immunoprecipitated using either anti-Desmoglein 1 or anti-Plakoglobin antibody in the same condition described above. Immunoprecipitants were separated on gels, transferred onto PVDF membrane and probed with anti-Desmoglein 1, -Plakoglobin, -c-Met and -E-cadherin antibodies.
Detection of HGF expression by RT ± PCR and ELISA
Total RNA was isolated from the cell lines using Trizol Reagent (Gibco-BRL). Reverse transcription was carried using the Superscript II system (Gibco-BRL). PCR primers for ampli®cation of HGF were: forward primer: 5'-TCC-CCATCGCCATCCCC-3'; reverse primer: 5'-CACCATG-GCCTCGGCTGG-3'. The expected size of PCR product is 749 bp. Internal control primers (forward: 5'-TGACGGGG-TCACCCACACTGTGCCCATCTA-3; reverse: 5'-CTAGA-AGCATTTGCGGTGGACGATGGAGGG-3') ampli®ed a 650 bp fragment of b-actin. PCR was performed using 1.5 U Taq DNA polymerase (Gibco-BRL), 0.4 mM dNTPs (Pharmacia), 2 mM MgCl 2 in 16PCR buer (Gibco-BRL). PCR was started with a 5-min denaturation at 958C, after which ampli®cation was performed for 30 cycles of denaturation at 948C for 1 min, annealing at 658C for 1.5 min, and elongation at 728C for 1 min. Samples were analysed by electrophoresis in 1.5% agarose gels containing 0.5 mg/ml ethidium bromide.
To detect secreted HGF by cells, conditioned media were collected, centrifuged to remove cellular debris, diluted to appropriate concentrations and subjected to enzyme linked immunosorbent assay (ELISA). ELISA was performed according to the conditions suggested by the manufacturer (R&D Systems, Minneapolis, MN, USA).
Cell adhesion assay
Melanocytes or E-cadherin-positive, Desmoglein-positive melanoma cells infected with indicated adenoviruses were pre-labeled with a¯uorescent dye DiI (10 mg/ml; Molecular Probes, Eugene, OR, USA) for 2 h, washed with HBSS and harvested by treatment with 0.01% trypsin in HBSS containing 1 mM calcium for 30 min at 378C. Under these conditions, cadherins are speci®cally protected from proteolytic digestion. Cells were then resuspended in assay medium (HBSS containing 1% bovine serum albumin and 1 mM calcium). About 5000 cells were added to keratinocyte monolayer in 8-well chamber slides and allowed to adhere for 30 min. After removal of nonadherent cells, slides were ®xed. Numbers of adherent cells per high power ®eld in triplicate wells were counted under a¯uorescence microscope.
Abbreviations AKT, murine thymoma viral (v-akt) oncogene homologue; bFGF, basic ®broblast growth factor; DMEM, Dulbecco's modi®ed Eagle's medium; Dsg3DEC, Desmoglein 3 mutant with extracellular domain deleted; E-cadDEC, E-cadherin mutant with extracellular domain deleted; ELISA, enzyme linked immunosorbent assay; FBS, fetal bovine serum; HGF, hepatocyte growth factor; IGF-R1, insulin-like growth factor receptor 1; MAPK, mitogen-activated protein kinase; PI3K, phosphatidyl-inositol-3-kinase.
